X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (98131) 98131
Newsletter (5939) 5939
Newspaper Article (5307) 5307
Book Chapter (483) 483
Magazine Article (319) 319
Dissertation (89) 89
Book / eBook (82) 82
Web Resource (64) 64
Trade Publication Article (41) 41
Reference (24) 24
Transcript (16) 16
Book Review (15) 15
Conference Proceeding (15) 15
Publication (14) 14
Report (14) 14
Paper (4) 4
Streaming Video (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67207) 67207
female (37768) 37768
male (36371) 36371
middle aged (23033) 23033
infectious diseases (22685) 22685
mortality (21857) 21857
animals (21617) 21617
adult (21269) 21269
bacterial infections (20925) 20925
infections (20902) 20902
microbiology (20673) 20673
anti-bacterial agents - therapeutic use (20564) 20564
aged (19238) 19238
health aspects (17380) 17380
pneumonia (17377) 17377
antibiotics (16039) 16039
research (15385) 15385
bacteria (14932) 14932
risk factors (14752) 14752
infection (14511) 14511
bacterial pneumonia (12845) 12845
immunology (12426) 12426
analysis (10873) 10873
research article (10722) 10722
epidemiology (10231) 10231
adolescent (10183) 10183
retrospective studies (10106) 10106
medicine (10024) 10024
treatment outcome (9049) 9049
child (8746) 8746
anti-bacterial agents - pharmacology (8564) 8564
diagnosis (8327) 8327
aged, 80 and over (8297) 8297
care and treatment (8288) 8288
medical research (7984) 7984
mice (7970) 7970
child, preschool (7410) 7410
sepsis (7353) 7353
infant (7232) 7232
pathogens (7157) 7157
hospitals (7104) 7104
drug resistance (7041) 7041
disease (6791) 6791
microbial sensitivity tests (6787) 6787
surgery (6728) 6728
multidisciplinary sciences (6673) 6673
medicine, experimental (6476) 6476
children (6340) 6340
patients (6288) 6288
science (6229) 6229
pharmacology & pharmacy (6198) 6198
prospective studies (6090) 6090
young adult (5881) 5881
pediatrics (5772) 5772
anti-bacterial agents - administration & dosage (5662) 5662
virulence (5496) 5496
studies (5491) 5491
medicine, general & internal (5478) 5478
bacteremia (5394) 5394
management (5375) 5375
proteins (5345) 5345
infant, newborn (5311) 5311
bacterial infections and mycoses (5303) 5303
prevalence (5214) 5214
risk-factors (5116) 5116
nosocomial infections (5111) 5111
drug resistance in microorganisms (5032) 5032
prognosis (4954) 4954
prevention (4905) 4905
incidence (4698) 4698
vaccines (4696) 4696
internal medicine (4617) 4617
drug resistance, bacterial (4421) 4421
time factors (4418) 4418
inflammation (4407) 4407
antimicrobial agents (4327) 4327
respiratory system (4276) 4276
medicine & public health (4261) 4261
therapy (4245) 4245
infectious disease (4203) 4203
drug therapy (4127) 4127
tuberculosis (4109) 4109
resistance (4044) 4044
public health (3978) 3978
laboratories (3835) 3835
usage (3687) 3687
biology (3667) 3667
identification (3664) 3664
staphylococcus aureus (3628) 3628
escherichia-coli (3592) 3592
abridged index medicus (3491) 3491
medicine and health sciences (3479) 3479
risk (3468) 3468
genes (3466) 3466
bacterial diseases (3461) 3461
biology and life sciences (3375) 3375
medicine, research & experimental (3367) 3367
meningitis (3367) 3367
veterinary sciences (3367) 3367
physiological aspects (3345) 3345
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Online Resources - Online (5) 5
UofT at Scarborough - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
St. Michael's Hospital - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (108049) 108049
Spanish (786) 786
French (742) 742
German (695) 695
Portuguese (524) 524
Japanese (357) 357
Russian (179) 179
Turkish (150) 150
Chinese (130) 130
Italian (128) 128
Dutch (80) 80
Polish (73) 73
Danish (59) 59
Norwegian (58) 58
Hungarian (43) 43
Korean (43) 43
Czech (39) 39
Romanian (37) 37
Swedish (23) 23
Bulgarian (20) 20
Arabic (15) 15
Serbian (14) 14
Hebrew (13) 13
Lithuanian (13) 13
Persian (13) 13
Croatian (9) 9
Icelandic (7) 7
Finnish (5) 5
Slovak (5) 5
Afrikaans (2) 2
Bosnian (1) 1
Greek (1) 1
Hindi (1) 1
Ukrainian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial stewardship oversight significantly... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Objective. We compared differences in the hospital charges, length of hospital stay, and mortality between patients with healthcare- and community-associated bloodstream infections, urinary tract infections... 
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | MORTALITY | INFECTIOUS DISEASES | ESCHERICHIA-COLI | EUROPEAN HOSPITALS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | IMMUNOLOGY | METHICILLIN-RESISTANCE | ENTEROCOCCUS | BACTEREMIA | STAPHYLOCOCCUS-AUREUS | BURDEN | BLOOD-STREAM INFECTIONS | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | and Commentaries
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0167522
In this study, we retrospectively reviewed the clinical experience of patients receiving doripenem-containing regimens for the treatment of healthcare-associated infections (HCAIs... 
IN-VITRO | MULTICENTER | BACTERIAL-INFECTIONS | IMIPENEM-CILASTATIN | EFFICACY | VENTILATOR-ASSOCIATED PNEUMONIA | SAFETY | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | SURVEILLANCE | ANTIMICROBIAL ACTIVITY | Soft Tissue Infections - mortality | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Male | Tertiary Care Centers - statistics & numerical data | Hospital Mortality - trends | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Cross Infection - pathology | Respiratory Tract Infections - mortality | Soft Tissue Infections - pathology | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Urinary Tract Infections - pathology | Retrospective Studies | Soft Tissue Infections - drug therapy | Respiratory Tract Infections - pathology | Intraabdominal Infections - microbiology | Respiratory Tract Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Intraabdominal Infections - mortality | Intraabdominal Infections - pathology | Soft Tissue Infections - microbiology | Carbapenems - therapeutic use | Cross Infection - microbiology | Aged | Intraabdominal Infections - drug therapy | APACHE | Infection | Doripenem | Care and treatment | Dosage and administration | Health care | Therapy | Pneumonia | Intensive care | Health services | Medical records | Infections | Urinary tract | Drug resistance | Respiratory tract | Respiratory tract diseases | Urinary tract infections | Urogenital system | Pathogens | Ventilators | Medical research | Statistical analysis | Bacterial infections | Review boards | Mortality | Antimicrobial agents | Patients | Abdomen | Urinary tract diseases | Medicine | Studies | Hospitals | Antibiotics | Pharmacy | Skin | Adults
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2012, Volume 55, Issue 7, pp. 943 - 950
Journal Article
by Gutiérrez-Gutiérrez, Belén and Salamanca, Elena and de Cueto, Marina and Hsueh, Po-Ren and Viale, Pierluigi and Paño-Pardo, José Ramón and Venditti, Mario and Tumbarello, Mario and Daikos, George and Cantón, Rafael and Doi, Yohei and Tuon, Felipe Francisco and Karaiskos, Ilias and Pérez-Nadales, Elena and Schwaber, Mitchell J and Azap, Özlem Kurt and Souli, Maria and Roilides, Emmanuel and Pournaras, Spyros and Akova, Murat and Pérez, Federico and Bermejo, Joaquín and Oliver, Antonio and Almela, Manel and Lowman, Warren and Almirante, Benito and Bonomo, Robert A and Carmeli, Yehuda and Paterson, David L and Pascual, Alvaro and Rodríguez-Baño, Jesús and del Toro, M D and Gálvez, J and Falcone, M and Russo, A and Giamarellou, H and Trecarichi, E M and Losito, A R and García-Vázquez, E and Hernández, A and Gómez, J and Bou, G and Iosifidis, E and Prim, N and Navarro, F and Mirelis, B and Skiada, A and Origüen, J and Juan, R San and Fernández-Ruiz, M and Larrosa, N and Puig-Asensio, M and Cisneros, J M and Molina, J and González, V and Rucci, V and de Gopegui, E Ruiz and Marinescu, C I and Martínez-Martínez, L and Fariñas, M C and Cano, M E and Gozalo, M and Mora-Rillo, M and Francisco, C Navarro-San and Peña, C and Gómez-Zorrilla, S and Tubau, F and Tsakris, A and Zarkotou, O and Antoniadou, A and Poulakou, G and Pitout, J and Virmani, D and Torre-Cisneros, J and Guzmán-Puche, J and Helvaci, Ö and Sahin, A O and Pintado, V and Ruiz, P and Bartoletti, M and Giannella, M and Tacconelli, E and Riemenschneider, F and Calbo, E and Badia, C and Xercavins, M and Gasch, O and Fontanals, D and Jové, E and REIPI/ESGBIS/INCREMENT Investigators and REIPI ESGBIS INCREMENT
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 726 - 734
Journal Article
American journal of transplantation, ISSN 1600-6135, 01/2018, Volume 18, Issue 1, pp. 197 - 206
...‐sufficient phenotypes, respectively). We aimed to evaluate the incidence and severity of infection, rejection, and survival within 1 year after liver transplantation (LT... 
liver allograft function/dysfunction | translational research/science | genetics | infectious disease | clinical research/practice | infection and infectious agents | liver disease:immune/inflammatory | liver transplantation/hepatology | SOLID-ORGAN TRANSPLANTATION | SURGERY | practice | COMPLEMENT | inflammatory | hepatology | CYTOMEGALOVIRUS | GENE POLYMORPHISMS | dysfunction | TRANSPLANTATION | DEFINITIONS | clinical research | PATHWAY | science | translational research | liver disease:immune | liver allograft function | liver transplantation | Prognosis | Prospective Studies | Follow-Up Studies | Liver Transplantation - adverse effects | Bacterial Infections - etiology | Humans | Middle Aged | Male | Mannose-Binding Lectin - genetics | Graft Rejection - mortality | Adult | Female | Graft Rejection - pathology | Postoperative Complications | Genetic Predisposition to Disease | Risk Factors | Genotype | Graft Rejection - etiology | Graft Survival | Liver Transplantation - mortality | Survival Rate | Polymorphism, Genetic | Bacterial Infections - pathology | Aged | Tissue Donors | Bacterial Infections - mortality | Mannose-Binding Lectin - deficiency | Pneumonia | Bacterial infections | Bacterial pneumonia | Genes | Liver | Mortality | Antifungal agents | Mycoses | Septic shock | Transplantation | Risk factors | Genetic polymorphisms | Monosaccharides | Lectins | Health aspects | Sugars | Cytomegalovirus | Transplants & implants | Syngeneic grafts | Infections | Mannose | Graft rejection | Serum levels | Confidence intervals | Allografts | Donors | Mannose-binding lectin | Bacteria | Sepsis | Liver transplantation
Journal Article
Infection control and hospital epidemiology, ISSN 1559-6834, 2016, Volume 27, Issue 4, pp. 349 - 356
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2013, Volume 58, Issue 2, pp. 371 - 379
.... End points were mortality, morbidity, graft-related complications, or reinfection. Results Twenty males and four females with median age of 70 years (range, 35-80 years... 
Surgery | SURGERY | MANAGEMENT | CRYOPRESERVED ARTERIAL HOMOGRAFTS | MYCOTIC-ANEURYSMS | RECONSTRUCTION | EXTRAANATOMIC BYPASS | STENT GRAFT INFECTION | PERIPHERAL VASCULAR DISEASE | SINGLE-CENTER | EXPERIENCE | PROSTHETIC GRAFTS | ANEURYSM REPAIR | Predictive Value of Tests | Recurrence | Blood Vessel Prosthesis - adverse effects | Device Removal - adverse effects | Humans | Middle Aged | Staphylococcal Infections - surgery | Male | Tomography, X-Ray Computed | Prosthesis Design | Streptococcal Infections - mortality | Anti-Bacterial Agents - therapeutic use | Aortography - methods | Endovascular Procedures - instrumentation | Prosthesis Failure | Blood Vessel Prosthesis Implantation - adverse effects | Prosthesis-Related Infections - microbiology | Time Factors | Aged, 80 and over | Adult | Female | Prosthesis-Related Infections - diagnosis | Retrospective Studies | Staphylococcal Infections - microbiology | Prosthesis-Related Infections - mortality | Reoperation | Streptococcal Infections - microbiology | Hospital Mortality | Aortic Aneurysm - mortality | Blood Vessel Prosthesis Implantation - instrumentation | Device Removal - mortality | Endovascular Procedures - adverse effects | Aortic Aneurysm - surgery | Treatment Outcome | Coated Materials, Biocompatible | Endovascular Procedures - mortality | Blood Vessel Prosthesis Implantation - mortality | Prosthesis-Related Infections - surgery | Staphylococcal Infections - mortality | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Streptococcal Infections - surgery | Aged | Aneurysms | Complications and side effects | Care and treatment | Patient outcomes
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 11, p. e0166527
Objectives we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000-2013) in a Swedish county. Methods retrospective cohort study... 
BACTEREMIA | MULTIDISCIPLINARY SCIENCES | SEPTIC SHOCK | HOSPITALS | SECULAR TRENDS | HEALTH-CARE | OUTCOMES | BURDEN | SEVERE SEPSIS | PATHOGENS | Multivariate Analysis | Humans | Middle Aged | Candidiasis - epidemiology | Gram-Positive Bacterial Infections - mortality | Bacteremia - mortality | Male | Candidiasis - microbiology | Fungemia - mortality | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Candidiasis - drug therapy | Fungemia - drug therapy | Gram-Positive Bacterial Infections - microbiology | Female | Retrospective Studies | Cross Infection - epidemiology | Comorbidity | Risk Factors | Bacteremia - drug therapy | Candidiasis - mortality | Gram-Negative Bacterial Infections - drug therapy | Fungemia - microbiology | Sweden - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Health Surveys | Cross Infection - microbiology | Survival Analysis | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Aged | Fungemia - epidemiology | Gram-Positive Bacterial Infections - drug therapy | Community-Acquired Infections | Gram-Negative Bacterial Infections - mortality | Surveys | Medical research | Mortality | Medicine, Experimental | Health aspects | Risk factors | Health care | Health sciences | Hospital costs | Laboratories | Infections | Patient admissions | Risk analysis | Patients | Incidence | Medicine | Studies | Infectious diseases | Antibiotics | Surveillance | Population | Sepsis | Trends | Inhabitants
Journal Article